Medicare Enrolled

Dr. Daniel Lemor, M.D.

Cornea and External Diseases Specialist Physician · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4036 WHITTIER BLVD STE 202, Los Angeles, CA 90023
3232623333
In practice since 2014 (12 years)
NPI: 1275950115 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lemor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lemor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lemor

Dr. Daniel Lemor is a cornea and external diseases specialist physician in Los Angeles, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Lemor performed 441 Medicare services across 341 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lemor received a total of $1,440 from 16 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cornea and external diseases specialist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lemor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 441 Medicare services $1,440 industry payments

Medicare Practice Summary

Medicare Utilization ↗
441
Medicare services
Bottom 28% in CA for cornea and external diseases specialist physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
341
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
176 $68 $110
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
124 $96 $160
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
43 $30 $150
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
32 $22 $25
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
23 $105 $195
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
18 $50 $150
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
14 $136 $405
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $80 $111
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,440
Total received (2018-2024)
Avg $240/year across 6 years
Bottom 31% in CA for cornea and external diseases specialist physician
16
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,440 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$689
2023
$142
2022
$150
2021
$324
2020
$121
2018
$15

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$462
Astellas Pharma Global Development
$130
ABBVIE INC.
$71
Tarsus Pharmaceuticals, Inc.
$26
Top 3 companies account for 96.3% of 2024 payments
All-time payments by company (2018-2024) ›
SUN PHARMACEUTICAL INDUSTRIES INC.
$500
Aerie Pharmaceuticals, Inc.
$179
Astellas Pharma Global Development
$130
Sun Pharmaceutical Industries Inc.
$117
Oyster Point Pharma, Inc.
$100
Novartis Pharmaceuticals Corporation
$96
ABBVIE INC.
$93
Eyevance Pharmaceuticals LLC
$37
Akorn Operating Company LLC
$33
BioTissue Holdings, Inc.
$30
Allergan, Inc.
$27
Tarsus Pharmaceuticals, Inc.
$26
Mallinckrodt Hospital Products Inc.
$24
Carl Zeiss Meditec AG
$19
Allergan Inc.
$15
Dompe US, Inc.
$14
Top 3 companies account for 56.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · COMBIGAN · Cequa · DURYSTA · Flarex · Izervay · LUMIGAN · None Specified · OXERVATE · PROKERA · TYRVAYA · Tobradex ST · XDEMVY · XIIDRA · Zioptan · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cornea and external diseases specialist physician in Los Angeles?
Compare cornea and external diseases specialist physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse cornea and external diseases specialist physicians nearby

Geographic Context

Cornea and external diseases specialist physicians within 10 mi
12
Per 100K population
0.1
County median income
$87,760
Nearest hospital
EAST LOS ANGELES DOCTORS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lemor is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lemor experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Lemor performed 176 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lemor receive payments from pharmaceutical companies?
Yes. Dr. Lemor received a total of $1,440 from 16 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lemor's costs compare to other cornea and external diseases specialist physicians in Los Angeles?
Dr. Lemor's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lemor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →